Market Research Logo

Cryptosporidiosis - Pipeline Review, H2 2018

Cryptosporidiosis - Pipeline Review, H2 2018

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cryptosporidiosis - Pipeline Review, H2 2018, provides an overview of the Cryptosporidiosi


Introduction
Global Markets Direct Report Coverage
Cryptosporidiosis - Overview
Cryptosporidiosis - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Cryptosporidiosis - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Cryptosporidiosis - Companies Involved in Therapeutics Development
AbbVie Inc
ioGenetics Inc
Novartis AG
Romark Laboratories LC
Cryptosporidiosis - Drug Profiles
clofazimine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
DBAF-201 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
KDU-731 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
RM-5038 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit CDPK1 for Protozoal Infections - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Cryptosporidiosis - Dormant Projects
Cryptosporidiosis - Discontinued Products
Cryptosporidiosis - Product Development Milestones
Featured News & Press Releases
Mar 14, 2018: Calibr's repurposed drug to treat non-viral diarrhea enters into a clinical trial
Feb 14, 2018: Novartis forms alliance to develop medicines for treating infectious diarrheal disease
May 31, 2017: Progress reported in global fight against diarrheal disease cryptosporidiosis
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Cryptosporidiosis, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products under Development by Universities/Institutes, H2 2018
Products under Development by Companies, H2 2018
Products under Development by Universities/Institutes, H2 2018
Number of Products by Stage and Target, H2 2018
Number of Products by Stage and Mechanism of Action, H2 2018
Number of Products by Stage and Route of Administration, H2 2018
Number of Products by Stage and Molecule Type, H2 2018
Cryptosporidiosis - Pipeline by AbbVie Inc, H2 2018
Cryptosporidiosis - Pipeline by ioGenetics Inc, H2 2018
Cryptosporidiosis - Pipeline by Novartis AG, H2 2018
Cryptosporidiosis - Pipeline by Romark Laboratories LC, H2 2018
Cryptosporidiosis - Dormant Projects, H2 2018
Cryptosporidiosis - Discontinued Products, H2 2018
List of Figures
Number of Products under Development for Cryptosporidiosis, H2 2018
Number of Products by Stage and Routes of Administration, H2 2018
Number of Products by Molecule Types, H2 2018
Number of Products by Stage and Molecule Types, H2 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report